KRYS stock forecast
Our latest prediction for Krystal Biotech Inc's stock price was made on the June 5, 2023 when the stock price was at 121.79$.
In the short term (2weeks), KRYS's stock price should underperform the market by -3.95%. During that period the price should oscillate between -9.57% and +3.12%.
In the medium term (3months), KRYS's stock price should underperform the market by -28.31%. During that period the price should oscillate between -31.41% and +6.77%.
Get email alertsCreate a solid portfolio with KRYS
About Krystal Biotech Inc
krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that “nature operates in the shortest way possible”. (aristotle)
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -5.41$ per share.
The book value per share is 4.12$
Three months stock forecastJune 5, 2023
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -153M | - | -123M | -5.41 | - | - | 27M | 4.12 | - | - | - |